Omvik P, Lund-Johansen P
J Hypertens. 1984 Feb;2(1):73-80. doi: 10.1097/00004872-198402000-00013.
Captopril is an orally active converting enzyme inhibitor lowering blood pressure (BP) in different types of hypertension. A combination of captopril and a diuretic is often used in the treatment of severe hypertension. We have examined the chronic haemodynamic effect of combined captopril and hydrochlorothiazide treatment at rest and during 50 and 100 W dynamic exercise in 12 patients with severe therapy resistant essential hypertension. Blood pressure was measured intra-arterially before and after a mean treatment period of 8.7 months. Cardiac index (CI) was measured by dye dilution (Cardiogreen) and body fluid volumes by radioisotope dilution techniques. During rest sitting BP was reduced by 31/17 mmHg (15%) from a pretreatment value of 205/119 mmHg. Total peripheral resistance index (TPRI) fell 17% whereas CI, heart rate (HR) and stroke index (SI) did not show any significant changes. The fall in mean arterial pressure (MAP) was slightly less during exercise (12%) and the BP reduction was associated with a fall in CI and SI of 15 and 17%, respectively and no fall in TPRI. No significant changes were observed in body fluid volumes.
卡托普利是一种口服有效的转换酶抑制剂,可降低不同类型高血压患者的血压(BP)。卡托普利与利尿剂联合使用常用于治疗重度高血压。我们研究了12例重度治疗抵抗性原发性高血压患者在静息状态以及50瓦和100瓦动态运动时,联合使用卡托普利和氢氯噻嗪治疗的慢性血流动力学效应。在平均8.7个月的治疗期前后,通过动脉内测量血压。通过染料稀释法(Cardiogreen)测量心脏指数(CI),通过放射性同位素稀释技术测量体液容量。静息坐位时,血压从治疗前的205/119 mmHg降低了31/17 mmHg(15%)。总外周阻力指数(TPRI)下降了17%,而CI、心率(HR)和每搏指数(SI)未显示任何显著变化。运动期间平均动脉压(MAP)的下降略少(12%),血压降低分别与CI和SI下降15%和17%相关,而TPRI未下降。体液容量未观察到显著变化。